Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.

Stavroula AnastasopoulouMats A ErikssonMats HeymanChen WangRiitta NiinimäkiSirje MikkelGoda E VaitkevičienėInga Maria JohannsdottirIda Hed MyrbergOlafur Gisli JonssonBodil Als-NielsenKjeld SchmiegelowJoanna BanerjeeArja H Harila-SaariSusanna Ranta

Published in: Pediatric blood & cancer (2018)

PRES is a neurotoxicity in the treatment of childhood ALL with both acute and long-term morbidity. Older age, T-cell leukemia, CNS involvement and high-risk block treatment are risk factors for PRES.

Keyphrases

acute lymphoblastic leukemia
risk factors
young adults
bone marrow
acute myeloid leukemia
liver failure
intensive care unit
case report
respiratory failure
middle aged
smoking cessation
early life
community dwelling
acute respiratory distress syndrome